We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Change your protocol, update your authorisation, report safety issues, submit safety updates and complete your end-of-trial study report.
Information about when you need to submit substantial amendments to a clinical trial including changes to the trial sponsor or legal representative, Investigational medicinal product certification and importation.
Information for health professionals on the epidemiology, transmission and prevention of Chlamydia abortus which can cause stillbirth or abortion in humans.
The process for applicants applying for a Paediatric Investigation Plan (PIP) modification or waiver.
How to apply for a traditional herbal registration (THR) to market a herbal medicine in the UK.
Guidance for industry on flexible approaches to regulation we are taking during the COVID-19 outbreak.
Guidelines for commissioners, screening providers and programme managers for NHS cervical screening.
Applications received to amend the specification of a patent under sections 27 and 75 before the court and the Office.
The MHRA has approved the combined antibiotic cefepime/enmetazobactam (Exblifep 2 g/0.5 g powder for concentrate for solution for infusion)
The review of the safety of isotretinoin has concluded.
How to notify the MHRA of your intention to carry out a clinical investigation for medical devices.
Half a million women in England have accessed cheaper HRT - the main treatment for negative menopause symptoms - since last April.
How to show MHRA you're meeting good clinical practice (GCP) standards and what to expect from an inspection.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).